| __timestamp | Rhythm Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 5078000000 |
| Thursday, January 1, 2015 | 3425000 | 4717000000 |
| Friday, January 1, 2016 | 6311000 | 5096000000 |
| Sunday, January 1, 2017 | 9518000 | 4986000000 |
| Monday, January 1, 2018 | 28080000 | 4214000000 |
| Tuesday, January 1, 2019 | 36550000 | 3806000000 |
| Wednesday, January 1, 2020 | 46125000 | 3671000000 |
| Friday, January 1, 2021 | 68486000 | 3528000000 |
| Saturday, January 1, 2022 | 92032000 | 3445000000 |
| Sunday, January 1, 2023 | 117532000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Teva Pharmaceutical Industries Limited and Rhythm Pharmaceuticals, Inc. offer a fascinating study in contrasts. Over the past decade, Teva's SG&A expenses have consistently been higher, peaking at approximately $5 billion in 2016. In contrast, Rhythm Pharmaceuticals, a smaller player, has seen its SG&A costs rise from a modest $1.2 million in 2014 to $117 million in 2023, reflecting its growth trajectory. Despite Teva's larger scale, its SG&A expenses have decreased by about 32% from 2014 to 2023, indicating improved cost management. Meanwhile, Rhythm's expenses have surged, highlighting its aggressive expansion strategy. This comparison underscores the different challenges and strategies faced by established giants and emerging innovators in the pharmaceutical industry.
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Genmab A/S
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?